期刊文献+

G-CSF治疗后中性粒细胞反应预测重型再生障碍性贫血免疫抑制治疗早期疗效 被引量:6

Increasing peripheral blood neutrophils after G-CSF treatment is a predictor of early response to immunosuppressive therapy in severe aplastic anemia
原文传递
导出
摘要 目的 探讨重型/极重型再生障碍性贫血(SAA/VSAA)患者免疫抑制治疗(IST)前应用G-CSF治疗后的中性粒细胞反应(ANC反应)对于IST早期疗效的预测价值.方法 回顾性分析2005年9月至2011年11月行IST的SAA/VSAA共125例患者资料,对IST前应用G-CSF治疗后的ANC反应与IST近期疗效进行相关性分析,绘制G-CSF治疗后ANC增高程度(ΔANC)预测IST疗效的ROC曲线.结果 G-CSF治疗后ANC反应组IST后3个月(49.0%对28.9%,P=0.023)及6个月(61.2%对40.8%,P=0.026)血液学反应(HR)率明显高于无反应组;以G-CSF治疗10d内ΔANC≥0.5×10/9L作为ANC反应界值预测IST后3个月及6个月疗效最佳.多因素分析显示G-CSF治疗10d内ANC反应为IST后3个月HR的独立预后因素(P=0.004),但并非IST后6个月HR的独立预后因素.G-CSF治疗后获ANC反应组患者5年总生存率显著高于无反应组[(92.8±4.0)%对(69.5±6.5)%,P=0.025].结论 IST前G-CSF治疗后的ANC反应可提示骨髓残存造血,是方便、实用的预测患者接受IST早期疗效及长期生存的指标. Objective To testify whether absolute neutrophil count (ANC) response to preimmunosuppressive-therapy (pre-IST) granulocyte-stimulating factor (G-CSF) treatment could predict early response to IST in severe aplastic anemia (SAA).Methods Clinical data and hematologic response of 125 SAA patients treated with antithymocyte globulin (r-ATG) combined with cyclosporine were retrospectively analyzed.Correlation of ANC response to pre-IST G-CSF treatment and early response to IST were statistically analyzed,and receiver operating characteristic (ROC) curve was used to estimate the value of increased ANC (Δ ANC) in predicting early IST response.Results The hematologic response (HR) rate to IST in ANC reponded patients was significantly higher than non-responded group (3-month HR 49.0% vs 28.9%,P=0.023; 6-month HR 61.2% vs 40.8%,P=0.026).With ΔANC≥0.5× 109/L as cutoff level,the best point to predict early IST response was 10 days after G-CSF (d 10).Response of ANC to pre-IST G-CSF treatment at d 10 was among the independent factors of predicting 3-month (P=0.004),but not for 6-month response to IST.The overall 5-year survival rate was 92.8% and 69.5% in ANC responded and non-responed groups,respectively (P=0.025).Conclusion Responding to pre-IST G-CSF treatment reflected the residual bone marrow hematopoiesis,and could act as a convenient and practical predictor to early IST response as well as long-term survival in SAA.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2014年第11期974-979,共6页 Chinese Journal of Hematology
基金 卫生公益性行业科研专项(201202017) 天津市科委应用基础及前沿技术研究计划(11JCYBC10500) 临床医学专业学位研究生临床研究能力培养模式(PUMC-GS-2012009)
关键词 贫血 再生障碍性 粒细胞集落刺激因子 免疫抑制法 Anemia, aplastic Granulocyte colony-stimulating factor Immunosuppression
  • 相关文献

参考文献25

  • 1Camitta BM, Thomas ED, Nathan DG, et al. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality [J]. Blood, 1976, 48 ( 1 ): 63- 70.
  • 2Bacigalupo A, Hows J, Gluckman E, et al. Bone marrow trans- plantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party[J]. Br J Haematol, 1988, 70(2): 177-182.
  • 3Fuhrer M, Rampf U, Baumann I, et al. Immunosuppressive thera- py for aplastic anemia in children: a more severe disease predicts better survival[J]. Blood, 2005, 106(6): 2102-2104.
  • 4Chang MH, Kim KH, Kim HS, et al. Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia [J]. Eur J Haematol, 2010, 84 (2):154-159.
  • 5Yoshida N, Yagasaki H, Hama A, et al. Predicting response to immunosuppressive therapy in childhood aplastic anemia [J]. Haematologica, 2011, 96 (5): 771-774.
  • 6Bacigalupo A, Bruno B, Saracco P, et al. Antilymphocyte globu- lin, cyclosporine, prednisolone, and granulocyte colony-stimulat- ing factor for severe aplastic anemia: an update of the GITMO/ EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO) [ J ]. Blood, 2000, 95 (6): 1931-1934.
  • 7Tichelli A, Schrezenmeier H, Soci6 G, et al. A randomized con- trolled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation [J]. Blood, 2011, 117( 17): 4434-4441.
  • 8曹慧敏,王慧君,张莉,井丽萍,周康,杨栋林,李洪强,刘庆国,闫嶂松,刘永泽,吴玉红,储榆林,张凤奎.一线应用兔源抗胸腺细胞球蛋白联合环孢素治疗成人重型再生障碍性贫血疗效分析[J].中华血液学杂志,2011,32(1):38-42. 被引量:16
  • 9[No authors listed]. Incidence of aplastic anemia: the relevance of diagnostic criteria. By the International Agranulocytosis and Aplastic Anemia Study[J]. Blood, 1987, 70(6): 1718-1721.
  • 10Scheinberg P, Wu CO, Nunez O, et al. Predicting response to e therapy and survival in severe aplastic anaemia[J]. Br J Haematol, 2009, 144(2): 206-216.

二级参考文献32

  • 1Rosenfeld S,Follmann D,Nunez O,et al.Antithymocyte globulin and cyclosporine for severe aplastic anemia:association between hematologic response and long-term outcome.JAMA,2003,289:1130-1135.
  • 2Bacigalupo A,Bruno B,Saracco P,et al.Antilymphocyte globulin,cyclosporine,prednisolone,and granulocyte colony-stimulating factor for severe aplastic anemia:an update of the GITMO/EBMT study on 100 patients.Blood,2000,95:1931-1934.
  • 3Dincol G,Aktan M,Diz-Kücükkaya R,et al.Treatment of acquired severe aplastic anemia with antilymphocyte globulin,cyclosporin A,methyprednisolone,and granulocyte colony-stimulating factor.Am J Hematol,2007,82:783-786.
  • 4Scheinberg P,Nunez O,Young NS.Retreatment with rabbit antithymocyte globulin and cyclosporin for patients with relapsed or refractory severe aplastic anaemia.Br J Haematol,2006,133:622-627.
  • 5[No authors listed] Incidence of aplastic anaemia:relevance of diagnosis criteria.By the International Agranulocytosis and Aplastic Anemia Study.Blood,1987,70:1718-1721.
  • 6Camitta BM,Thomas ED,Nathan DG,et al.Severe aplastic anaemia:a prospective study of the effect of early marrow transplantation on acute mortality.Blood,1976,48:63-69.
  • 7Bacigalupo A,Hows JM,Gluckman E,et al.Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA):a report of the EBMT SAA Working Party.Br J Haematol,1988,70:177-182.
  • 8British commettee for standards in Haematology,Blood transfision Task Force.Guidelines for the use of platelet transfusions.Br J Haematol,2003,122:10-23.
  • 9di Bona E,Rodeghiero F,Bruno B,et al.Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy.Br J Haematol,1999,107:330-334.
  • 10Gupta V,Gordon-Smith EC,Cook G,et al.A third course of anti thymocyte globulin in aplastic anaemia is only beneficial in previous responders.Br J Haematol,2005,129:110-117.

共引文献20

同被引文献46

  • 1葸瑞,白海,王存邦.异基因造血干细胞移植治疗重型再生障碍性贫血[J].中国组织工程研究,2015,19(6):908-912. 被引量:7
  • 2王易,卢俊,李捷,李建琴,何海龙,肖佩芳.不同免疫抑制方案治疗儿童重型再生障碍性贫血疗效分析[J].中国血液流变学杂志,2005,15(4):598-600. 被引量:2
  • 3Young NS, Scheinberg R Calado RT. Aplastic anemia [J]. Curr Opin Hematol, 2008, 15 (3): 162- 168. doi: 10.1097/MOH. 0b013e3282fa7470.
  • 4Scheinberg E Aplastic anemia: therapeutic updates in immuno- suppression and transplantation [J]. Hematology Am Soc Hematol Educ Program, 2012, 2012:292-300. doi: 10.1182/ashe- ducation-2012.1.292.
  • 5Young ME, Potter V, Kulasekararaj AG, et al. Haematopoietic stem cell transplantation for acquired aplastic anaemia [J ]. Curr Opin Hematol, 2013, 20 (6):515-520. doi: 10.1097/MOH. 0b013e328365af83.
  • 6Doney K, Leisenring W, Storb R, et al. Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team [J]. Ann Intern Med, 1997, 126 (2): 107-115. doi: 10.7326/0003-4819-126-2-199701150-00003.
  • 7Fouladi M, Herman R, Rolland-Grinton M, et al. Improved survival in severe acquired aplastic anemia of childhood [J]. Bone Marrow Transplant. 2000, 26 ( 11 ): 1149-1156.
  • 8Bacigalupo A, Hows J, Gluckman E, et al. Bone marrow trans-plantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party[J]. Br J Haematol, 1988, 70 (2):177-182. doi: 10.111 l/j. 1365-2141.1988.tb02460.x.
  • 9Yagasaki H, Shichino H, Ohara A, et al. Immunosuppressive therapy with horse anti-thymocyte globulin and cyclosporine as treatment for fulminant aplastic anemia in children [J]. Ann Hematol, 2014, 93(5):747-752. doi: 10.1007/s00277-013-1984-x.
  • 10Kennedy-Nasser AA, Leung KS, Mahajan A, et al. Comparable outcomes of matched-related and altemative donor stem cell transplantation for pediatric severe aplastic anemia [J]. Biol Blood Marrow Transplant, 2006, 12 (12):1277- 1284. doi: 10.1016/j.bbmt.2006.07.011.

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部